Asymmetric synthesis and σ receptor affinity of enantiomerically pure 1,4-disubstituted tetrahydro-1H-3-benzazepines

Tetrahedron Asymmetry

Volumn 20, Issue 12, 2009, Pages 1383-1392

  Husain, Syed Masood ^a   Heim, Marie Theres ^a   Schepmann, Dirk ^a   Wünsch, Bernhard ^a  

^a INST OF REPRO MED OF THE UNIV   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

(1,4) 1 BENZYL 4 BUTYL 2,3,4,5 TETRAHYDRO 1H 3 BENZAZEPINE; (1,4) 1 BENZYL 4 ETHYL 2,3,4,5 TETRAHYDRO 1H 3 BENZAZEPINE; (1,4) 1 BENZYL 4 METHYL 2,3,4,5 TETRAHYDRO 1H 3 BENZAZEPINE; (1,4) 1 BENZYL 4 PHENYL 2,3,4,5 TETRAHYDRO 1H 3 BENZAZEPINE; (3,6,11A) 6 BENZYL 11A BUTYL 3 PHENYL 2,3,11,11A TETRAHYDRO(1,3)OXAZOLO(2,3 B)(3)BENZAZEPIN 5 (6H)ONE; (3,6,11A) 6 BENZYL 11A ETHYL 3 PHENYL 2,3,11,11A TETRAHYDRO(1,3)OXAZOLO(2,3 B)(3)BENZAZEPIN 5 (6H)ONE; (3,6,11A) 6 BENZYL 11A METHYL 3 PHENYL 2,3,11,11A TETRAHYDRO(1,3)OXAZOLO(2,3 B)(3)BENZAZEPIN 5 (6H)ONE; (3,6,11A) 6 BENZYL 11A METHYL 3 PHENYL 2,3,11,11A TETRAHYDRO(1,3)OXAZOLO(2,3 B)(3)BENZAZEPIN 6 (6H)ONE; (3,6,11A) 6 BENZYL 3,11A DIPHENYL 2,3,11,11A TETRAHYDRO(1,3)OXAZOLO(2,3 B)(3)BENZAZEPIN 5 (6H)ONE; (3,6,11A) 6 BENZYL 3,11A DIPHENYL 2,3,11,11A TETRAHYDRO(1,3)OXAZOLO(2,3 B)(3)BENZAZEPIN 5 (6H)ONE ENT; 2 [(1,4) 1 BENZYL 4 BUTYL 2,3,4,5 TETRAHYDRO 1H 3 BENZAZEPIN 3 YL] 2 PHENYLETHANOL; 2 [(1,4) 1 BENZYL 4 ETHYL 2,3,4,5 TETRAHYDRO 1H 3 BENZAZEPIN 3 YL] 2 PHENYLETHANOL; 2 [(1,4) 1 BENZYL 4 METHYL 2,3,4,5 TETRAHYDRO 1H 3 BENZAZEPIN 3 YL] 2 PHENYLETHANOL; 2 [(1,4) 1 BENZYL 4 PHENYL 2,3,4,5 TETRAHYDRO 1H 3 BENZAZEPIN 3 YL] 2 PHENYLETHANOL; BENZAZEPINE DERIVATIVE; BENZYL DERIVATIVE; DELTA OPIATE RECEPTOR; LACTAM DERIVATIVE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; ASYMMETRIC SYNTHESIS; BENZYLATION; CELL ASSAY; CHEMICAL MODIFICATION; CONTROLLED STUDY; DRUG DETERMINATION; DRUG PURITY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOMER; HYDROGENOLYSIS; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; REDUCTION; STEREOISOMERISM; SUBSTITUTION REACTION;

EID: 67649646687     PISSN: 09574166     EISSN: 1362511X     Source Type: Journal    
DOI: 10.1016/j.tetasy.2009.05.017     Document Type: Article

References (27)

1. Weinstock J., Hieble J.P., and Wilson III J.W. Drug Fut. 10 (1985) 645-697
2. Pettersson I., Liljefors T., and Bogeso K. J. Med. Chem. 33 (1990) 2197-2204
3. Wu W.L., Burnett D.A., and Spring R. J. Med. Chem. 48 (2005) 680-693
4. Johnson P.D., Aristoff P.A., Zurenko G.E., Schaadt R.D., Yagi B.H., Ford C.W., Hamel J.C., Stapert D., and Moerman J.K. Bioorg. Med. Chem. Lett. 13 (2003) 4197-4200
5. Kubata H., Kakefuda A., and Watanabe T. J. Med. Chem. 46 (2003) 4728-4740
6. Smith B.M., Smith J.M., Tsai J.H., Schultz J.A., Gilson C.A., Estrada S.A., Chen R.R., Park D.M., Prieto E.B., Gallardo C.S., Sengupta D., Thomsen W.J., Saldana H.R., Whelan K.T., Manzaghi F., Webb R.R., and Beeley N.R.A. Bioorg. Med. Chem. Lett. 15 (2005) 1467-1470
7. Smith B.M., Smith J.M., Tsai J.H., Schultz J.A., Gilson C.A., Estrada S.A., Chen R.R., Park D.M., Prieto E.B., Gallardo C.S., Sengupta D., Dosa P.I., Covel J.A., Ren A., Webb R.R., Beeley N.R.A., Martin M., Morgan M., Espitia S., Saldana H.R., Bjenning C., Whelan K.T., Grottick A.J., Manzaghi F., and Thomsen W.J. J. Med. Chem. 51 (2008) 305-313
8. Gnanalingham K.K., Hunter A.J., Jenner P., and Marsden C.D. Psychopharmacology 117 (1995) 403-412
9. Medhurst A.D., Atkins A.R., Beresford I.J., Brackenborough K., Briggs M.A., Calver A.R., Cilia J., Cluderay J.E., Crook B., Davis J.B., Davis R.K., Davis R.P., Dawson L.A., Foley A.G., Gartlon J., Gonzalez M.I., Heslop T., Hirst W.D., Jennings C., Jones D.N.C., Lacroix L.P., Martyn A., Ociepka S., Ray A., Regan C.M., Roberts J.C., Schogger J., Southam E., Stean T.O., Trail B.K., Upton N., Wadsworth G., Wald J.A., White T., Witherington J., Woolley M.L., Worby A., and Wilson D.M. J. Pharmacol. Exp. Therap. 321 (2007) 1032-1045
10. Krull O., and Wünsch B. Bioorg. Med. Chem. 12 (2004) 1439-1451
11. Wirt U., Schepmann D., and Wünsch B. Eur. J. Org. Chem. (2007) 462-475
12. Husain S.M., Fröhlich R., Schepmann D., and Wünsch B. J. Org. Chem. 74 (2009) 2788-2793
13. Martin W.R., Eades C.G., Thompson J.A., Huppler R.E., and Gilbert P.E. J. Pharmacol. Exp. Ther. 197 (1976) 517-532
14. Kaiser C., Pontecorvo J., and Mewshaw R.E. Neurotransm 7 (1991) 1-5
15. Walker J.M., Bowen W.D., Walker F.O., Matsumoto R.R., De Costa B., and Rice K.C. Pharmacol. Rev. 42 (1990) 353-402
16. Husain S.M., and Wünsch B. Synthesis (2008) 2729-2732
17. Husain S.M., Fröhlich R., and Wünsch B. Tetrahedron: Asymmetry 19 (2008) 1613-1616
18. Burgess L.E., and Meyers A.I. J. Org Chem. 57 (1992) 1656-1662
19. Ishihara K., Mori A., and Yamamoto H. Tetrahedron 46 (1990) 4595-4612
20. Maier C.A., and Wünsch B. J. Med. Chem. 45 (2002) 438-448
21. Carroll F.I., Abraham P., Parham K., Bai X., Zhang X., Brine G.A., Mascarella S.W., Martin B.R., May E.L., Sauss C., Di Paolo L., Wallace P., Walker J.M., and Bowen W.D. J. Med. Chem. 35 (1992) 2812-2818
22. May E.L., Aceto M.D., Bowman E.R., Bentley C., Martin B.R., Harris L.S., Medzihradsky F., Mattson M.V., and Jacobson A.E. J. Med. Chem. 37 (1994) 3408-3418
23. Lipton S.A. Nat. Rev. Drug Discovery 5 (2006) 160-170
24. Cheng Y., and Prusoff W.H. Biochem. Pharmacol. 22 (1973) 3099-3108
25. Bradford M.M. Anal. Biochem. 72 (1976) 248-254
26. De-Haven-Hudkins D.L., Fleissner L.C., and Ford-Rice F.Y. Eur. J. Pharmacol. Mol. Pharmacol. Sect. 227 (1992) 371-378
27. Mach R.H., Smith C.R., and Childers S.R. Life Sci. 57 (1995) 57-62